Ce Shi Selected Research

Ce Shi Research Topics

Disease

8	Neoplasms (Cancer) 10/2020 - 01/2015
5	Inflammation (Inflammations) 12/2021 - 06/2014
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2022 - 01/2017
4	Carcinogenesis 01/2022 - 08/2017
4	Leukemia 10/2021 - 01/2017
4	Ganglion Cysts (Ganglion) 10/2021 - 01/2018
4	Infections 01/2018 - 08/2015
3	Osteosarcoma (Osteogenic Sarcoma) 01/2022 - 10/2020
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2021 - 01/2018
3	Bone Resorption 03/2021 - 11/2014
3	Acute Promyelocytic Leukemia 09/2014 - 01/2013
2	Diabetic Retinopathy (Retinopathy, Diabetic) 10/2021 - 01/2020
2	Burns 08/2018 - 07/2018
2	Corneal Neovascularization 08/2018 - 07/2018
2	Residual Neoplasm 01/2017 - 08/2014
2	Tuberculosis (Tuberculoses) 08/2016 - 11/2011
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 04/2022
1	Chronic Hepatitis B 12/2021
1	Thrombosis (Thrombus) 11/2021
1	COVID-19 11/2021
1	Thrombocytopenia (Thrombopenia) 11/2021
1	Ischemia 10/2021
1	Edema (Dropsy) 10/2021
1	Metrorrhagia (Spotting) 01/2021
1	Spinal Stenosis (Stenosis, Spinal) 01/2021
1	Cognitive Dysfunction 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Chronic Pain 01/2021
1	Disease Progression 01/2021
1	Intervertebral Disc Displacement (Herniated Disc) 01/2021
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2021
1	Paresthesia (Dysesthesia) 01/2021
1	Retinoblastoma (Glioblastoma, Retinal) 09/2020
1	Parkinson Disease (Parkinson's Disease) 08/2020
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020
1	Colitis 01/2020
1	Dysbiosis 01/2020
1	Neuromyelitis Optica (Devic's Disease) 01/2020
1	Optic Neuritis (Retrobulbar Neuritis) 01/2020
1	Ischemic Stroke 01/2020
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2020
1	Stroke (Strokes) 01/2020
1	Hypertensive Retinopathy 01/2019
1	Hypertension (High Blood Pressure) 01/2019

Drug/Important Bio-Agent (IBA)

9	Retinaldehyde (Retinal)IBA 10/2021 - 02/2016
6	Proteins (Proteins, Gene)FDA Link 04/2022 - 01/2013
4	Arsenic Trioxide (Trisenox)FDA Link 12/2017 - 01/2013
3	venetoclaxIBA 04/2022 - 01/2020
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 08/2017
3	Pharmaceutical PreparationsIBA 01/2019 - 08/2016
2	Small Interfering RNA (siRNA)IBA 04/2022 - 09/2020
2	MicroRNAs (MicroRNA)IBA 10/2021 - 08/2017
2	AgarIBA 01/2021 - 10/2020
2	Messenger RNA (mRNA)IBA 01/2020 - 09/2017
2	HydrogelsIBA 01/2020 - 01/2019
2	GelatinIBA 01/2019 - 06/2014
2	AlkaliesIBA 08/2018 - 07/2018
2	Ophthalmic Solutions (Eye Drops)IBA 08/2018 - 07/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2018 - 01/2016
2	Biological ProductsIBA 01/2016 - 08/2014
1	Beclin-1IBA 04/2022
1	tyrosine receptor (receptor, tyrosine)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 12/2021
1	AutoantibodiesIBA 11/2021
1	COVID-19 VaccinesIBA 11/2021
1	Antiphospholipid AntibodiesIBA 11/2021
1	VaccinesIBA 11/2021
1	Platelet Factor 4IBA 11/2021
1	Biocompatible Materials (Biomaterials)IBA 03/2021
1	TitaniumIBA 03/2021
1	((3Z)- N- (3- chlorophenyl)- 3- ((3,5- dimethyl- 4- ((4- methylpiperazin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- N- methyl- 2- oxo- 2,3- dihydro- 1H- indole- 5- sulfonamide)IBA 03/2021
1	Rituximab (Mabthera)FDA Link 01/2021
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 01/2021
1	Cyclin AIBA 09/2020
1	CyclinsIBA 09/2020
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 05/2020
1	Amyloid (Amyloid Fibrils)IBA 01/2020
1	Adaptor Protein Complex 2IBA 01/2020
1	cobimetinibIBA 01/2020
1	alantolactoneIBA 01/2020
1	CytokinesIBA 01/2020
1	PolyphenolsIBA 01/2020
1	GelsIBA 01/2020
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019
1	5-methyltetrahydrofolateIBA 01/2019
1	Vitamin D FDA LinkGeneric 01/2019
1	ChitosanIBA 01/2019
1	HomocysteineIBA 01/2019

Therapy/Procedure

8	Therapeutics 04/2022 - 08/2015
2	Drug Therapy (Chemotherapy) 04/2022 - 09/2017
1	Guided Tissue Regeneration 12/2021
1	Conservative Treatment 01/2021
1	Decompression 01/2021
1	Diskectomy (Discectomy) 01/2021
1	Heterologous Transplantation (Xenotransplantation) 10/2020
1	Oral Administration 01/2020
1	Injections 01/2019